Welcome to our dedicated page for Bwx Technologies news (Ticker: BWXT), a resource for investors and traders seeking the latest updates and insights on Bwx Technologies stock.
BWX Technologies, Inc. (NYSE: BWXT) generates news across defense, clean energy, nuclear medicine, space exploration and environmental restoration because of its focus on nuclear technologies and engineering services. Company announcements highlight work in both Government Operations and Commercial Operations, including naval nuclear component production, special materials processing, commercial nuclear components, field services, fuel and fuel handling, and medical-related activities.
News for BWXT often covers contracts and projects tied to the U.S. Naval Nuclear Propulsion Program and the U.S. government. For example, the company has reported a U.S. Naval Nuclear Propulsion Program contract for the manufacture of naval nuclear reactor fuel through its subsidiary Nuclear Fuel Services, Inc., which supplies fuel used in U.S. Navy submarines and aircraft carriers. Updates can also involve advanced fuel technologies such as TRISO nuclear fuel and programs like Project Pele, a microreactor prototype that uses Generation IV high-temperature gas-cooled reactor technology.
Commercial and international project news includes roles such as Owner’s Engineer for new nuclear build projects and collaboration with advanced reactor developers. BWXT has announced Owner’s Engineer services for Bulgaria’s New Build Kozloduy Nuclear Power Plant Units 7 and 8 as part of a consortium, and agreements with Rolls-Royce SMR involving nuclear steam generator design and potential future component supply for small modular reactors. These items illustrate how BWXT participates in large nuclear energy projects and advanced reactor supply chains.
Investors and observers can also expect BWXT news about quarterly financial results, non-GAAP performance metrics, capital markets transactions such as convertible senior notes offerings, and changes in senior leadership roles reported through press releases and Form 8-K filings. For ongoing insight into BWXT’s contracts, advanced nuclear initiatives and financial updates, this news page aggregates company disclosures and related coverage in one place.
Summary not available.
BWX Technologies has secured a landmark contract with the U.S. Department of Energy valued at up to $45 billion over 10 years for environmental management operations at the Hanford Site in Washington. This contract, known as the Hanford Integrated Tank Disposition Contract (ITDC), is deemed the largest single contract award in the company's history. It involves a joint venture that includes BWXT and other companies, focusing on the complex task of radioactive waste cleanup. The award highlights BWXT's commitment to environmental stewardship and efficient operations. The scope of work includes managing tank farm facilities and other critical services. However, the company has cautioned that performance and future revenues depend on various risks and uncertainties, urging stakeholders not to rely solely on the contract value as an indicator of future results.
BWX Technologies, Inc. (NYSE: BWXT) has announced a significant $428 million contract awarded to its subsidiary, Nuclear Fuel Services, Inc. (NFS), by the National Nuclear Security Administration (NNSA). This five-year contract involves the purification and conversion of highly enriched uranium (HEU) and is vital for U.S. national security operations. NFS will set up a new process line at its Erwin, Tennessee facility to execute this contract, following a successful $57.5 million Phase I contract initiated in 2021. The NNSA aims to utilize NFS's services while modernizing its Y-12 National Security Complex. BWXT remains optimistic about meeting the contract's rigorous requirements, focusing on safety and quality.
BWX Technologies, Inc. (NYSE: BWXT) will release its first quarter 2023 results on May 8, 2023, after market close, followed by a conference call at 5:00 p.m. EDT. Investors can participate via a listen-only format and view a supporting presentation on the company’s website. For dial-in participation, the U.S. number is 1-833-470-1428 and the international number is 1-929-526-1599 with access code 698120. BWXT, a Fortune 1000 and Defense News Top 100 company, is headquartered in Lynchburg, Virginia. It specializes in nuclear solutions for security, clean energy, and environmental restoration with approximately 7,000 employees and 14 operating sites across the U.S., Canada, and the U.K.
BWX Technologies (NYSE: BWXT) announced a significant engineering contract with GE Hitachi Nuclear Energy for the BWRX-300 small modular reactor (SMR) reactor pressure vessel (RPV). The RPV, crucial for the reactor core, will undergo engineering analysis, design support, and manufacturing preparations. This contract highlights BWXT's engineering strengths and supports increasing interest in SMR development across North America and Europe. The BWRX-300 is projected to have lower capital costs per MW compared to other SMR designs, enhancing its market viability. Forward-looking statements caution about potential risks like project delays and modifications.
Summary not available.
BWX Technologies, Inc. (BWXT) reported Q4 2022 diluted GAAP EPS of $0.47, down 63% from $1.26 a year ago, with revenue of $624.2 million, a 5% increase year-over-year. For the full year, GAAP EPS decreased by 20% to $2.60, while adjusted EBITDA rose to $439.4 million. Operating cash flow for 2022 was $244.7 million. The company declared a quarterly cash dividend increase to $0.23 per share, payable on March 28, 2023. Despite solid results, labor market challenges are expected to hinder growth in 2023. BWXT's 2023 guidance estimates revenue of ~$2.4 billion and adjusted EBITDA of ~$475 million.
Ontario Power Generation's Darlington Nuclear Generating Station has successfully installed a new isotope system, enabling the production of life-saving Molybdenum-99 (Mo-99) isotopes, a first for a commercial reactor. This innovative production will help alleviate the long-standing shortages of Mo-99, crucial for generating Technetium-99m, a primary diagnostic imaging agent in nuclear medicine. The project, a collaboration between Laurentis Energy Partners and BWXT Medical Ltd., awaits final regulatory approvals from the FDA and Health Canada before commercial production begins. The facility can produce enough Mo-99 to meet a significant portion of North America's demand.
BWX Technologies, Inc. (NYSE: BWXT) will release its fourth quarter and full-year 2022 results on February 23, 2023, post-market. A conference call is scheduled for 5:00 p.m. EST, enabling listeners to join and view the presentation online. BWXT is headquartered in Lynchburg, Virginia, and is recognized as a leading innovator in nuclear solutions, serving sectors including global security and clean energy. The company has approximately 6,700 employees and operates major sites throughout the U.S., Canada, and the U.K., contributing to its critical roles in projects for the U.S. Department of Energy and NASA.
Fusion Pharmaceuticals and BWXT Medical have established a preferred partner agreement for the supply of actinium-225, enhancing Fusion's existing isotope supply for its clinical-stage radiopharmaceuticals. This strategic partnership is poised to support growing demand for targeted alpha therapies (TATs) while ensuring volume-based pricing. The collaboration emphasizes BWXT's commitment to meeting the global actinium supply needs, bolstering Fusion's clinical programs and future business opportunities.